Cumulative pregnancy rates after sequential treatment with modified natural cycle IVF followed by IVF with controlled ovarian stimulation

Human Reproduction

Volumn 23, Issue 8, 2008, Pages 1808-1814

  Pelinck, M J ^a   Knol, H M ^a   Vogel, N E A ^a   Arts, E G J M ^a   Simons, A H M ^a   Heineman, M J ^a,b   Hoek, A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Assisted reproduction; BESST; Cumulative pregnancy rate; Natural cycle; Ovarian stimulation

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; GONADORELIN ANTAGONIST; GONADOTROPIN; LEUPRORELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; BIRTH RATE; CELL SIZE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED OVARIAN STIMULATION; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; FOLLOW UP; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OOCYTE RETRIEVAL; OVARY FOLLICLE CELL; PREGNANCY RATE;

EID: 47649108061     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den155     Document Type: Article

References (26)

1. De Neubourg D, Gerris J. What about the remaining twins since single-embryo transfer? How far can (should) we go? Hum Reprod 2006;21:843-846.
2. Elizur SE, Aslan D, Shulman A, Weisz B, Bider D, Dor J. Modified natural cycle using GnRH antagonist can be an optional treatment in poor responders undergoing IVF. J Assist Reprod Genet 2005;22:75-79.
3. Elizur SE, Lerner-Geva L, Levron J, Shulman A, Bider D, Dor J. Cumulative birth rate following in vitro fertilization: study of 5310 cycles. Gynecol Endocrinol 2006;22:25-30.
4. Fauser BCJM, Bouchard P, Coelingh Bennink HJT, Collins JA, Devroey P, Evers JLH, van Steirteghem A. Alternative approaches in IVF. Hum Reprod Update 2002;8:1-9.
5. Gordts S, Campo R, Puttemans P, Brosens I, Valkenburg M, Norre J, Renier M, Coeman D, Gordts S. Belgian legislation and the effect of elective single embryo transfer on IVF outcome. Reprod Biomed Online 2005;10:436- 441.
6. Goverde AJ, McDonnell J, Vermeiden JPW, Schats R, Rutten FFH, Schoemaker J. Intrauterine insemination or in vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet 2000;355:13-18.
7. Groen H, Pelinck MJ, Hoek A, ten Vergert EM. Cost-effectiveness of in-vitro fertilisation (IVF) in the manipulated natural cycle versus conventional IVF. Ital J Public Health 2005;3:181.
8. Heijnen EM, Macklon NS, Fauser BC. What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment. Hum Reprod 2004;19:1936-1938.
9. Heijnen EM, Eijkemans MJ, De Klerk C, Polinder S, Beckers NG, Klinkert ER, Broekmans FJ, Passchier J, Te Velde ER, Macklon NS et al. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet 2007;369:743-749.
10. Højgaard A, Ingerslev HJ, Dinesen J. Friendly IVF: patient opinions. Hum Reprod 2001;16:1391-1396.
11. Kadoch JJK, Frydman NNF, Castelo Branco AAC, Lédéé Bataille N, Franchin RRF, Frydman RRF. IVF-ET using naturally-selected dominant follicles for poor prognosis patients: a hypothesis. Fertil Steril 2003;80(Suppl 3):P-199.
12. Keizer M, Schelling K, Pelinck M, Hoek A, Simons A, Heineman M. Larger birth weight in singletons born after minimal stimulation IVF compared to singletons born after COH-IVF. Fertil Steril 2005;84:O-198.
13. Kolibianakis E, Zikopoulos K, Camus M, Tournaye H, Van Steirteghem A, Devroey P. Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation. Hum Reprod 2004;19:2545-2549.
14. Nargund G, Fauser BC, Macklon NS, Ombelet W, Nygren K, Frydman Rfor the Rotterdam ISMAAR Consensus Group on Terminology for Ovarian Stimulation for IVF. The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod 2007;22:2801-2804.
15. Pelinck MJ, Vogel NEA, Hoek A, Simons AHM, Arts EGJM, Mochtar MH, Beemsterboer S, Hondelink MN, Heineman MJ. Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: a multicentre cohort study. Hum Reprod 2006;21:2375- 2383.
16. Pelinck MJ, Vogel NE, Arts EG, Simons AH, Heineman MJ, Hoek A. Cumulative pregnancy rates after a maximum of nine cycles of modified natural cycle IVF and analysis of patient drop-out: a cohort study. Hum Reprod 2007;22:2463-2470.
17. Pistorius EN, Adang EM, Stalmeier PF, Braat DD, Kremer JA. Prospective patient and physician preferences for stimulation or no stimulation in IVF. Hum Fertil (Camb) 2006;9:209-216.
18. Ramsewak SS, Kumar A, Welsby R, Mowforth A, Lenton EA, Cooke ID. Is analgesia required for transvaginal single-follicle aspiration in in vitro fertilization? A double-blind study. J In Vitro Fert Embryo Transf 1990;7:103-106.
19. Rongières-Bertrand C, Olivennes F, Righini C, Fanchin R, Taïeb J, Hamamah S, Bouchard P, Frydman R. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation. Hum Reprod 1999;14:683-688.
20. Tiitinen A, Unkila-Kallio L, Halttunen M, Hyden-Granskog C. Impact of elective single embryo transfer on the twin pregnancy rate. Hum Reprod 2003;18:1449-1453.
21. Ubaldi F, Rienzi L, Baroni E, Ferrero S, Iacobelli M, Minasi M, Martinez F, Greco E. GnRH antagonist and natural ICSI cycle in poor responder patients. Hum Reprod 2003;18 S1:P-327.
22. Vail A, Gardener. Common statistical errors in the design and analysis of subfertility trials. Hum Reprod 2003;18:1000-1004.
23. Vogel NEA, Pelinck MJ, Arts EGJM, Hoek A, Simons AHM, Heineman MJ. Effectiveness of the modified natural cycle ICSI: results of a pilot study. Fertil Steril 2003;80(Suppl 3):P-7.
24. Weghofer A, Margreiter M, Bassim S, Sevelda U, Beilhack E, Feichtinger W. Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age. Fertil Steril 2004;81:1002-1006.
25. Witsenburg C, Dieben S, Van der Westerlaken L, Verburg H, Naaktgeboren N. Cumulative live birth rates in cohorts of patients treated with in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril 2005;84:99-107.
26. Zhioua F, Zhioua A, Chaker A, M'Solly S, Meriah S. Efficacy of intracytoplasmic sperm injection in a natural cycle with GnRH antagonists. Hum Reprod 2004;19 S1:P-299.